Your browser doesn't support javascript.
loading
A National Registry for People With All Stages of Kidney Disease: The National Kidney Foundation (NKF) Patient Network.
Inker, Lesley A; Ferrè, Silvia; Baliker, Mary; Barr, Anne; Bonebrake, Lisa; Chang, Alexander R; Chaudhari, Juhi; Cooper, Kerry; Diamantidis, Clarissa J; Forfang, Derek; Gillespie, Barbara; Gregoriou, Petros; Gwadry-Sridhar, Femida; Ladin, Keren; Maxwell, Cari; Mitchell, Kristi R; Murphy, Kathleen P; Rakibuz-Zaman, Muhammad; Rocco, Michael V; Spry, Leslie A; Sharma, Amit; Tangri, Navdeep; Warfield, Curtis; Willis, Kerry.
Afiliación
  • Inker LA; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts. Electronic address: linker@tuftsmedicalcenter.org.
  • Ferrè S; National Kidney Foundation, New York, New York.
  • Baliker M; National Kidney Foundation, New York, New York.
  • Barr A; Brown and Toland, Oakland, California.
  • Bonebrake L; Alport Syndrome Foundation, Scottsdale, Arizona.
  • Chang AR; Kidney Health Research Institute, Geisinger Health, Danville, Pennsylvania.
  • Chaudhari J; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
  • Cooper K; AstraZeneca, Wilmington, Delaware.
  • Diamantidis CJ; Divisions of General Internal Medicine and Nephrology and Department of Population Health Science, School of Medicine, Duke University, Durham, North Carolina.
  • Forfang D; National Kidney Foundation, New York, New York.
  • Gillespie B; Labcorp Drug Development, Princeton, New Jersey; Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.
  • Gregoriou P; National Kidney Foundation, New York, New York.
  • Gwadry-Sridhar F; Pulse Infoframe, London, Ontario, Canada.
  • Ladin K; Departments of Occupational Therapy and Community Health, Tufts University, Medford, Massachusetts.
  • Maxwell C; National Kidney Foundation, New York, New York.
  • Mitchell KR; Health Equity Outcomes Inc., Vienna, Virginia.
  • Murphy KP; Novartis Pharmaceuticals, East Hanover, New Jersey.
  • Rakibuz-Zaman M; Pulse Infoframe, London, Ontario, Canada.
  • Rocco MV; Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Spry LA; Lincoln Nephrology & Hypertension, Lincoln, Nebraska.
  • Sharma A; Bayer Pharmaceuticals, Cambridge, Massachusetts.
  • Tangri N; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Warfield C; National Kidney Foundation, New York, New York.
  • Willis K; National Kidney Foundation, New York, New York.
Am J Kidney Dis ; 81(2): 210-221.e1, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36191726
ABSTRACT
RATIONALE &

OBJECTIVE:

The National Kidney Foundation (NKF) launched the first national US kidney disease patient registry, the NKF Patient Network, that is open to patients throughout the continuum of chronic kidney disease (CKD). The Network provides individualized education and will facilitate patient-centered research, clinical care, and health policy decisions. Here, we present the overall design and the results of a feasibility study that was conducted July through December 2020. STUDY

DESIGN:

Longitudinal observational cohort study of patient-entered data with or without electronic health care record (EHR) linkage in collaboration with health systems. SETTING &

PARTICIPANTS:

People with CKD, age≥18 years, are invited through their provider, NKF communications, or national outreach campaign. People self-enroll and share their data through a secure portal that offers individualized education and support. The first health system partner is Geisinger. EXPOSURE Any cause and stage of CKD, including dialysis and kidney transplant recipients.

OUTCOME:

Feasibility of the EHR data transfer, participants' characteristics, and their perspectives on usability and content. ANALYTICAL

APPROACH:

Data were collected and analyzed through the registry portal powered by the Pulse Infoframe healthie 2.0 platform.

RESULTS:

During the feasibility study, 80 participants completed their profile, and 42 completed a satisfaction survey. Mean age was 57.5 years, 51% were women, 83% were White, and 89% were non-Hispanic or Latino. Of the participants, 60% were not aware of their level of estimated glomerular filtration rate and 91% of their urinary albumin-creatinine ratio.

LIMITATIONS:

Challenges for the Network are lack of awareness of kidney disease for many with CKD, difficulty in recruiting vulnerable populations or those with low digital readiness, and loss to follow-up, all leading to selection bias.

CONCLUSIONS:

The Network is positioned to become a national and international platform for real-world data that can inform the development of patient-centered research, care, and treatments.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Kidney Dis Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Kidney Dis Año: 2023 Tipo del documento: Article